Endometriosis Market Expansion Outlook: $2.21 Billion by 2029 Forecast

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Is The Predicted Market Size Trajectory For The Endometriosis Market From 2025 To 2034?

The endometriosis market size has experienced significant growth in recent years. It is anticipated to expand from $1.4 billion in 2024 to $1.54 billion by 2025, exhibiting a compound annual growth rate (CAGR) of 9.8%. This historical growth can be attributed to factors such as delayed diagnosis and increased awareness, progress in laparoscopic surgery, the availability of hormonal therapies, and the emergence of patient advocacy and support groups.

The endometriosis market size is projected to experience robust growth in the upcoming years. It is anticipated to reach “$2.21 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 9.4%. This anticipated expansion during the forecast period is primarily driven by factors such as minimally invasive procedures, significant pharmaceutical innovations, advancements in genetic and epigenetic research, and the worldwide expansion of women’s healthcare services. Key developments expected within the forecast period encompass a shift towards patient-centered care, the adoption of precision medicine, the rise of virtual care and telemedicine, and increased focus on fertility preservation.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13035&type=smp

Which Drivers Are Shaping The Endometriosis Industry’s Market Share?

The rising occurrence of ovarian cancer is anticipated to fuel the expansion of the endometriosis market in the future. Ovarian cancer is defined as a malignancy originating in the ovaries, which are female reproductive organs vital for producing eggs, estrogen, and progesterone hormones. A heightened risk of developing epithelial ovarian cancer, specifically the endometrioid and clear cell cancer subtypes, is linked to endometriosis. These subtypes are marked by elevated estrogen concentrations, which in turn can escalate the likelihood of developing ovarian cancer. For example, the American Cancer Society, a US-based professional organization, predicted in January 2023 that roughly 19,710 new cases of ovarian cancer would be diagnosed among women in the US during 2023. Additionally, data from the Ovarian Cancer Research Alliance, a US-based not-for-profit organization, indicated that ovarian cancer resulted in 12,810 deaths in 2022, a figure that climbed to 13,270 fatalities in 2023. Consequently, the growing incidence of ovarian cancer is propelling the growth of the endometriosis market.

What Are The Major Segments Identified In The Endometriosis Market?

The endometriosismarket covered in this report is segmented –

1) By Type: Superficial Peritoneal Lesion; Endometrioma; Deeply Infiltrating Endometriosis; Other Types

2) By Treatment Type: Hormonal Therapy; Pain Management

3) By Drug: Oral Contraceptives; Progestins; Nonsteroidal Anti-Inflammatory Drugs (NSAIDs); Gonadotropin Releasing Hormone (GnRH) Analogues; Levonorgestrel-Releasing Intrauterine Devices (LNR-IUDs); Other Drugs

4) By End-User: Hospitals; Homecare; Specialty Centers; Other End-Users

Subsegments:

1) By Superficial Peritoneal Lesion: Endometriotic Nodules; Peritoneal Endometriosis

2) By Endometrioma: Chocolate Cysts

3) By Deeply Infiltrating Endometriosis: Bowel Endometriosis; Ureteral Endometriosis; Vaginal Endometriosis

4) By Other Types: Abdominal Endometriosis; Thoracic Endometriosis

Which Market Trends Are Creating New Opportunities In The Endometriosis Industry?

Major companies in the endometriosis market are concentrating on developing innovative drugs such as Myfembree and securing approvals to introduce new treatment options for patients. The launch of novel endometriosis medications responds to a previously unfulfilled requirement for effective therapies. For instance, in August 2022, Myovant Sciences GmbH, a Switzerland-based biopharmaceutical company, along with Pfizer Inc., a US-based pharmaceutical industry company, obtained approval for Myfembree from the U.S. Food and Drug Administration (FDA) for addressing moderate to severe pain related to endometriosis in premenopausal women. Myfembree is a once-daily pill comprising three essential ingredients: relugolix, estradiol, and norethindrone acetate. It delivers proven relief for premenopausal women with two indications in a single pill. This offers an alternative treatment choice for women who cannot or choose not to use hormone therapy.

Which Key Market Players Are Investing In Expansion And Innovation Of Endometriosis Market?

Major companies operating in the endometriosis market are Pfizer Inc., F. Hoffmann-La Roche AG, Merck And Co. Inc., Abbvie Inc., Bayer AG, Bristol-Myers Squibb Company, GlaxoSmithKline PLC, AstraZeneca PLC, Abbott Laboratories, Eli Lilly and Company, Mylan N.V., Astellas Pharma Inc., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Limited, Ipsen Pharma Biotech S.A.S., Cadila Pharmaceuticals Ltd., Gedeon Richter PLC, Torrent Pharmaceuticals Ltd., Neurocrine Biosciences Inc., Ferring Pharmaceuticals, Prestige Consumer Healthcare Inc., Almirall S.A, Evotec BioSystems GmbH, Serum Institute of India Pvt. Ltd., Kissei Pharmaceutical Co. Ltd., Sanofi India Ltd., DebioPharm Group, Repros Therapeutics Inc., Meditrina Pharmaceuticals Private Limited, Zenomed Healthcare Private Limited.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/endometriosis-global-market-report

How Is Endometriosis Market Demand Varying Across Different Regions?

North America was the largest region in the endometriosis market in 2024. The regions covered in endometriosis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Request A Customized Version Of The Endometriosis Market Report:

https://www.thebusinessresearchcompany.com/customise?id=13035&type=smp

Browse Through More Reports Similar to the Global Endometriosis Market 2025, By The Business Research Company

Female Fertility And Pregnancy Rapid Test Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/female-fertility-and-pregnancy-rapid-test-global-market-report

Fertility Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/fertility-drugs-global-market-report

Fertility Services Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/fertility-services-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795